Energie- und Ressourceneffizienz an der Hochschule Reutlingen: Betriebshalle, Vorlesungsgebäude Textil & Design, Hochschulservicezentrum

In der heutigen Zeit ist es wichtig mit den Ressourcen sparsam umzugehen. Deshalb wird in dieser Projektarbeit die Ressourcen- und Energieeffizienz der Hochschule Reutlingen untersucht. Mit dem Aufzeigen der Potentiale in diesem Bereich können Kosten eingespart und die Umweltbelastung der Hochschule verringert werden. Es handelt sich hierbei um eine Erstanalyse mit begrenztem Detaillierungsgrad. Dieser beinhaltet den aktuellen Status quo in Bezug auf elektrische Energie, Wärmeenergie, Wasserverbrauch und Gas. Mit Hilfe einer Verbraucheranalyse werden die Hauptverbraucher ermittelt. Anhand dieser Ergebnisse werden dann die wesentlichen Potentiale deutlich gemacht. Aus Gründen der begrenzten Zeit und der Komplexität des Themas wird nach dem Pareto- Prinzip (20/80 Regel) vorgegangen. Es soll ein Gesamtüberblick über die Ressourcennutzung geschaffen und Ansatzpunkte für spätere Projektarbeiten ermittelt werden. Die Bewertung der Wirtschaftlichkeit dieser Potentiale ist aus zeitlichen Gründen kein Bestandteil dieser Projektarbeit

The aza-Morita-Baylis-Hillman reaction of electronically and sterically deactivated substrates.

The aza-Morita–Baylis–Hillman (azaMBH) reaction has been studied for electronically and sterically deactivated Michael acceptors. It is found that electronically deactivated systems can be converted with electron-rich phosphanes and pyridines as catalysts equally well. For sterically deactivated systems clearly better catalytic turnover can be achieved with pyridine catalysts. This is in accordance with the calculated affinities of the catalysts towards different Michael-acceptors

Generalized dynamical phase reduction for stochastic oscillators

Phase reduction is an important tool for studying coupled and driven oscillators. The question of how to generalize phase reduction to stochastic oscillators remains actively debated. In this work, we propose a method to derive a self-contained stochastic phase equation of the form $d\vartheta = a_\vartheta(\vartheta)dt + \sqrt{2D_\vartheta(\vartheta)}\,dW_\vartheta(t)$ that is valid not only for noise-perturbed limit cycles, but also for noise-induced oscillations. We show that our reduction captures the asymptotic statistics of qualitatively different stochastic oscillators, and use it to infer their phase-response properties.Comment: 12 pages, 7 figure

Learning Colour Representations of Search Queries

Image search engines rely on appropriately designed ranking features that capture various aspects of the content semantics as well as the historic popularity. In this work, we consider the role of colour in this relevance matching process. Our work is motivated by the observation that a significant fraction of user queries have an inherent colour associated with them. While some queries contain explicit colour mentions (such as 'black car' and 'yellow daisies'), other queries have implicit notions of colour (such as 'sky' and 'grass'). Furthermore, grounding queries in colour is not a mapping to a single colour, but a distribution in colour space. For instance, a search for 'trees' tends to have a bimodal distribution around the colours green and brown. We leverage historical clickthrough data to produce a colour representation for search queries and propose a recurrent neural network architecture to encode unseen queries into colour space. We also show how this embedding can be learnt alongside a cross-modal relevance ranker from impression logs where a subset of the result images were clicked. We demonstrate that the use of a query-image colour distance feature leads to an improvement in the ranker performance as measured by users' preferences of clicked versus skipped images.Comment: Accepted as a full paper at SIGIR 202

Methyl cation affinity (MCA) values for phosphanes

International audienceMethyl cation affinity (MCA) values have been calculated for a variety of phosphanes at the MP2(FC)/6-31+G(2d,p)//B98/6-31G(d) level of theory. The analysis of MCA values for tri-alkyl phosphanes reveals that substituent effects are additive for unbranched and cyclic alkyl substituents, and (with some modification) also for most of the branched alkyl substituents

A Novel Technique to Improve Anastomotic Perfusion Prior to Esophageal Surgery: Hybrid Ischemic Preconditioning of the Stomach. Preclinical Efficacy Proof in a Porcine Survival Model

Esophagectomy often presents anastomotic leaks (AL), due to tenuous perfusion of gastric conduit fundus (GCF). Hybrid (endovascular/surgical) ischemic gastric preconditioning (IGP), might improve GCF perfusion. Sixteen pigs undergoing IGP were randomized: (1) Max-IGP (n = 6): embolization of left gastric artery (LGA), right gastric artery (RGA), left gastroepiploic artery (LGEA), and laparoscopic division (LapD) of short gastric arteries (SGA); (2) Min-IGP (n = 5): LGA-embolization, SGA-LapD; (3) Sham (n = 5): angiography, laparoscopy. At day 21 gastric tubulation occurred and GCF perfusion was assessed as: (A) Serosal-tissue-oxygenation (StO2) by hyperspectral-imaging; (B) Serosal time-to-peak (TTP) by fluorescence-imaging; (C) Mucosal functional-capillary-density-area (FCD-A) index by confocal-laser-endomicroscopy. Local capillary lactates (LCL) were sampled. Neovascularization was assessed (histology/immunohistochemistry). Sham presented lower StO2 and FCD-A index (41 ± 10.6%; 0.03 ± 0.03 respectively) than min-IGP (66.2 ± 10.2%, p-value = 0.004; 0.22 ± 0.02, p-value < 0.0001 respectively) and max-IGP (63.8 ± 9.4%, p-value = 0.006; 0.2 ± 0.02, p-value < 0.0001 respectively). Sham had higher LCL (9.6 ± 4.8 mL/mol) than min-IGP (4 ± 3.1, p-value = 0.04) and max-IGP (3.4 ± 1.5, p-value = 0.02). For StO2, FCD-A, LCL, max- and min-IGP did not differ. Sham had higher TTP (24.4 ± 4.9 s) than max-IGP (10 ± 1.5 s, p-value = 0.0008) and min-IGP (14 ± 1.7 s, non-significant). Max- and min-IGP did not differ. Neovascularization was confirmed in both IGP groups. Hybrid IGP improves GCF perfusion, potentially reducing post-esophagectomy AL

Development of a Novel Valve-Controlled Drug-Elutable Microstent for Microinvasive Glaucoma Surgery: In Vitro and Preclinical In Vivo Studies

Purpose: Microinvasive glaucoma surgery (MIGS) has become an important treatment approach for primary open-angle glaucoma, although the safe and long-term effective lowering of intraocular pressure with currently available implants for MIGS is not yet achieved to a satisfactory extent. The study focusses on the development and in vitro and in vivo testing of a novel microstent for MIGS. Methods: A silicone elastomer-based microstent was developed. Implants were manufactured using dip coating, fs-laser cutting, and spray coating. Within the current study no antifibrotic drug was loaded into the device. Sterilized microstents were analyzed in vitro regarding pressure–flow characteristics and biocompatibility. Six New Zealand white rabbits were implanted with a microstent draining the aqueous humor from the anterior chamber into the subconjunctival space. Drainage efficacy was evaluated using oculopressure tonometry as a transient glaucoma model. Noninvasive imaging was performed. Results: Microstents were manufactured successfully and characterized in vitro. Implantation in vivo was successful for four animals with additional device fixation. Without additional fixation, dislocation of microstents was found in two animals. Safe and effective intraocular pressure reduction was observed for the four eyes with correctly implanted microstent during the 6-month trial period. Conclusions: The described microstent represents an innovative treatment approach for MIGS. The incorporation of a selectively antifibrotic drug into the microstent drugelutable coating will be addressed in future investigations. Translational Relevance: The current preclinical study successfully provided proof of concept for our microstent for MIGS which is suitable for safe and effective intraocular pressure reduction and offers promising perspectives for the clinical management of glaucoma

Impact of Partial Volume Correction on [18F]GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal Syndrome.

Corticobasal syndrome (CBS) is a rare neurodegenerative condition characterized by four-repeat tau aggregation in the cortical and subcortical brain regions and accompanied by severe atrophy. The aim of this study was to evaluate partial volume effect correction (PVEC) in patients with CBS compared to a control cohort imaged with the 18-kDa translocator protein (TSPO) positron emission tomography (PET) tracer [18F]GE-180. Eighteen patients with CBS and 12 age- and sex-matched healthy controls underwent [18F]GE-180 PET. The cortical and subcortical regions were delineated by deep nuclei parcellation (DNP) of a 3D-T1 MRI. Region-specific subcortical volumes and standardized uptake values and ratios (SUV and SUVr) were extracted before and after region-based voxel-wise PVEC. Regional volumes were compared between patients with CBS and controls. The % group differences and effect sizes (CBS vs. controls) of uncorrected and PVE-corrected SUVr data were compared. Single-region positivity in patients with CBS was assessed by a >2 SD threshold vs. controls and compared between uncorrected and PVE-corrected data. Smaller regional volumes were detected in patients with CBS compared to controls in the right ventral striatum (p = 0.041), the left putamen (p = 0.005), the right putamen (p = 0.038) and the left pallidum (p = 0.015). After applying PVEC, the % group differences were distinctly higher, but the effect sizes of TSPO uptake were only slightly stronger due to the higher variance after PVEC. The single-region positivity of TSPO PET increased in patients with CBS after PVEC (100 vs. 83 regions). PVEC in the cortical and subcortical regions is valuable for TSPO imaging of patients with CBS, leading to the improved detection of elevated [18F]GE-180 uptake, although the effect sizes in the comparison against the controls did not improve strongly

Association of Neurofilament Light Chain, [18F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With β-Amyloid-Negative CBS

Background and ObjectivesCorticobasal syndrome (CBS) with underlying 4-repeat tauopathy is a progressive neurodegenerative disease characterized by declining cognitive and motor functions. Biomarkers for assessing pathologic brain changes in CBS including tau-PET, 18 kDa translocator protein (TSPO)-PET, structural MRI, neurofilament light chain (NfL), or glial fibrillary acidic protein (GFAP) have recently been evaluated for differential diagnosis and disease staging, yet their association with disease trajectories remains unclear. Therefore, we performed a head-to-head comparison of neuroimaging (tau-PET, TSPO-PET, structural MRI) and plasma biomarkers (NfL, GFAP) as prognostic tools for longitudinal clinical trajectories in beta-amyloid (A beta)-negative CBS.MethodsWe included patients with clinically diagnosed A beta-negative CBS with clinical follow-up data who underwent baseline structural MRI and plasma-NfL analysis for assessing neurodegeneration, [F-18]PI-2620-PET for assessing tau pathology, [F-18]GE-180-PET for assessing microglia activation, and plasma-GFAP analysis for assessing astrocytosis. To quantify tau and microglia load, we assessed summary scores of whole-brain, cortical, and subcortical PET signal. For structural MRI analysis, we quantified subcortical and cortical gray matter volume. Plasma NfL and GFAP values were assessed using Simoa-based immunoassays. Symptom progression was determined using a battery of cognitive and motor tests (i.e., Progressive Supranuclear Palsy Rating Scale [PSPRS]). Using linear mixed models, we tested whether the assessed biomarkers at baseline were associated with faster symptom progression over time (i.e., time x biomarker interaction).ResultsOverall, 21 patients with A beta-negative CBS with similar to 2-year clinical follow-up data were included. Patients with CBS with more widespread global tau-PET signal showed faster clinical progression (PSPRS: B/SE = 0.001/0.0005, p = 0.025), driven by cortical rather than subcortical tau-PET. By contrast, patients with higher global [F-18]GE-180-PET readouts showed slower clinical progression (PSPRS: B/SE = -0.056/0.023, p = 0.019). No association was found between gray matter volume and clinical progression. Concerning fluid biomarkers, only higher plasma-NfL (PSPRS: B/SE = 0.176/0.046, p < 0.001) but not GFAP was associated with faster clinical deterioration. In a subsequent sensitivity analysis, we found that tau-PET, TSPO-PET, and plasma-NfL showed significant interaction effects with time on clinical trajectories when tested in the same model.Discussion[F-18]PI-2620 tau-PET, [F-18]GE-180 TSPO-PET, and plasma-NfL show prognostic potential for clinical progression in patients with A beta-negative CBS with probable 4-repeat tauopathy, which can be useful for clinical decision-making and stratifying patients in clinical trials